NTBLQ (Notable Labs) Net Margin %: -260,950.00% (As of Jun. 2024)


What is Notable Labs Net Margin %?

Notable Labs NTBLQ -90.00% Net Margin % is -260,950.00% as of Jun. 2024.

Net margin is calculated as Net Income divided by its Revenue. Notable Labs's Net Income for the three months ended in Jun. 2024 was $-5.22 Mil. Notable Labs's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Notable Labs's net margin for the quarter that ended in Jun. 2024 was -260,950.00%.

The historical rank and industry rank for Notable Labs's Net Margin % or its related term are showing as below:


NTBLQ's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Notable Labs  (OTCPK:NTBLQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Notable Labs Net Margin % Related Terms

Notable Labs Net Margin % Historical Data

* Premium members only.

The historical data trend for Notable Labs's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs Net Margin % Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Net Margin %
-5,632.28 -180,087.50 -3,633.55

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Net Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 -376,600.00 -260,950.00

NTBLQ vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Notable Labs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Net Margin % distribution charts can be found below:

* The bar in red indicates where Notable Labs's Net Margin % falls into.


Notable Labs Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Notable Labs's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-11.264/0.31
=-3,633.55 %

Notable Labs's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-5.219/0.002
=-260,950.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -260,950.00% mean?
Notable Labs (NTBLQ) has a Net Margin % of -260,950.00% as of Jun. 2024. Net margin is the ratio of total net income to net sales. View historical data on Notable Labs and its competitors.
Is Notable Labs' Net Margin % too high?
Notable Labs' current Net Margin % is -260,950.00%.
How does Notable Labs' Net Margin % compare to VRTX and REGN?
Notable Labs' Net Margin % of -260,950.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Notable Labs and its competitors. Notable Labs's current Net Margin % is -260,950.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current Net Margin % of -260,950.00%. The current Net Margin % is -260,950.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current Net Margin % is -260,950.00% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Notable Labs Business Description

Address 320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.